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Abstract
Objectives: First, to assess whether hospitals in states requiring explicit patient consent (“opt-
in”) for health information exchange (HIE) are more likely to report regulatory barriers to HIE. 
Second, to analyze whether these policies correlate with hospital volume of HIE.
Study Design: Cross-sectional analysis of US non-federal acute care hospitals in 2016.
Methods: We combined legal scholarship surveying HIE-relevant state laws with the AHA 
Annual IT Supplement for regulatory barriers and hospital characteristics. Data from CMS reports 
for hospitals attesting to Meaningful Use Stage 2 in 2016 (MU2, renamed “Promoting 
Interoperability” in 2018) captured hospital HIE volume. We used multivariate logistic regression 
and linear regression to estimate the association between opt-in state consent policies and reported 
regulatory barriers and HIE volume, respectively.
Results: Hospitals in states with opt-in consent policies were 7.8 percentage points more likely 
than hospitals in opt-out states to report regulatory barriers to HIE (p=0.03). In subgroup analyses, 
this finding held among hospitals that did not attest to MU2 (7.7pp, p=0.02). Among hospitals 
attesting, we did not find a relationship between opt-in policies and regulatory barriers (8.0pp, 
p=0.13), nor evidence of a relationship between opt-in policies and HIE volume (ß=0.56, p=0.76).
Conclusions: Our findings suggest that opt-in consent laws may carry greater administrative 
burdens compared to opt-out policies. However, less technologically advanced hospitals may bear 
more of this burden. Furthermore, opt-in policies may not impact HIE volume for hospitals that 
have already achieved a degree of technological sophistication. Policymakers should carefully 
consider the incidence of administrative burdens when crafting laws pertaining to HIE.
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Opt-in patient consent requirements for health information exchange correlate with more reported 
regulatory barriers, especially among less technologically advanced hospitals.
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Introduction
Policymakers continue to advance interoperable health information exchange (HIE) as an 
important goal for the US health care system.1,2 One of the anticipated benefits of HIE is 
reduced administrative burden of data sharing, which in turn can give providers more 
complete information at the point of care.3–5 Digitization of the US health care system has 
brought us closer to realizing this goal through the HITECH Act’s incentives for hospitals 
and physician practices to adopt increasingly sophisticated electronic health records (EHRs).
5,6 These incentives included supplementary Medicare reimbursements for hospitals that 
successfully demonstrated “meaningful use” of EHR functionality.5 In the case of HIE, this 
consisted of sending electronic summaries of care during care transitions.4 Despite these 
incentives, HIE capabilities among hospitals have continued to lag behind.7,8 As patients 
struggle with a lack of infrastructure for exchange between providers,9 hospitals have their 
own administrative burdens to enabling HIE, including the complex regulatory environment 
governing HIE across states;10 which can create significant barriers for hospitals who 
already face uncertain incentives to share patient data.
Perhaps the biggest legal challenge to a robust national HIE infrastructure is the varied state 
policies regarding patient consent for data exchange.10 State variation in consent policies 
comes from different approaches to default patient consent assumptions. States generally 
have either “opt-in” or “opt-out” patient consent requirements, although some have 
ambiguous or undefined patient consent policies.11 Opt-in states like New York assume no 
patient consent and therefore require explicit consent from each patient to allow providers to 
share and access that patient’s information via the HIE. (10 NY ADC § 300.5) Opt-out states 
like Kansas assume patient consent for exchange, but allow patients the opportunity to 
decline exchange. (KSA § 65–6832) Rates of non-participation in HIE have been found to 
vary by consent policy, with more than 95% of patients participating under opt-out scenarios 
and only 19% participating in opt-in settings,10 consistent with the behavioral economics 
literature.12–15 In the case that a patient chooses to not participate in HIE, that patient’s 
information is not permitted to be shared or sent outside of the organization collecting the 
information. Disallowing this sharing would in turn depress the overall volume of HIE 
observed at the organization. Therefore, one would expect organizations under opt-in 
policies to engage in less exchange due to lower patient participation rates.
Despite this potential impact of opt-in consent policies on HIE, we are aware of no national 
studies of the impact of these laws on hospitals’ barriers to and volume of HIE. Previous 
studies have examined patient decisions in the context of a single HIE and individual 
patient-level factors associated with opt-in to health information exchange data sharing.16,17 
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These studies provide important insight into the factors related to patients’ HIE consent 
decisions, and imply that there is significant administrative cost to obtaining patient consent. 
Research at the organizational level has found that policies requiring explicit (i.e. opt-in) 
consent correlate with lower volume of clinical document exchange.18 Finally, two 
nationwide studies have found the presence of consent laws to be associated with increased 
participation in HIE efforts.19,20 Importantly, these studies compared the presence of explicit 
consent laws to the lack of consent laws, as unclear legal environments (i.e. when no consent 
laws exist) often require organizations to behave as conservatively as possible. To advance 
this literature, it is important to also study the nature of these laws. However, we are aware 
of no studies directly comparing opt-in and opt-out consent policies at the state level to 
determine if opt-in approaches lead to perceived regulatory barriers to HIE for hospitals and, 
in turn, reduced HIE volume.
The purpose of our study was two-fold. First, we aimed to estimate the relationship between 
state laws governing patient consent requirements and hospitals’ probability of reporting 
regulatory and compliance barriers to HIE. Our second aim was to examine the extent to 
which these laws correlated with the level of hospital engagement in HIE. We anticipate our 
findings to be of interest to both state and federal policymakers and regulators currently 
crafting regulations for the future of health information exchange in the 21st Century Cures 
Act.21 Understanding the impact of different regulatory approaches to health information 
exchange on creating barriers for hospital participation and volume of data sharing is critical 
to informing the construction of future HIE infrastructure.
Methods
Setting and Data Sources
We used the American Hospital Association (AHA) Annual Survey and AHA Annual 
Survey - IT Supplement for 2016, as well as hospital-level Meaningful Use Stage 2 (MU2, 
renamed “Promoting Interoperability” in 2018) performance measures. The AHA Annual 
Survey is sent annually to the CEO of every hospital in the United States, with a request to 
complete it or designate completion to the most knowledgeable person in the organization. 
Respondents receive multiple mailings and follow-up phone calls. The 2016 survey was 
fielded in the period of November 2016 – April 2017, and the IT Supplement received a 
response rate of 58%. We limited our sample to non-federal, acute care hospitals in order to 
construct the largest sample of comparable hospitals in the data, especially those subject to 
similar market forces. This sample construction allows for comparison with the existing 
literature discussing hospital IT adoption and use.6,22,23 Our analytic sample included 2,613 
hospitals.
We merged this data with 2016 publicly reported MU2 health information exchange 
performance measures using the hospital’s National Provider Identifier (NPI) to obtain the 
level of HIE usage for each hospital. MU2 performance measures are derived from the 
Medicare incentive program for hospitals and providers to adopt and use increasingly 
sophisticated health IT. Hospitals report performance measures annually, with successful 
attestation translating into increased reimbursements from Medicare. This data was available 
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only for hospitals that had attested to MU2 in 2016, limiting our sub-sample for this analysis 
to 1,135 hospitals.
Measures
Regulatory Barriers to Health Information Exchange—For our first aim examining 
the relationship between consent policy and hospitals experiencing regulatory barriers to 
HIE, our dependent variable was hospital-reported regulatory barriers to HIE. In the AHA 
survey, hospitals describe “barriers when trying to electronically (not eFax) send, receive, or 
find (query) patient health information to/from other care settings or organizations.” We 
classified hospitals as experiencing regulatory barriers to HIE if they responded “Yes” to the 
following barrier: “The complexity of state and federal privacy and security regulations 
makes it difficult for us to determine whether it is permissible to electronically exchange 
patient health information.”
Hospital Health Information Exchange Volume—For our second aim evaluating the 
relationship between state laws and the amount of HIE in which a hospital engaged, our 
primary dependent variable was hospital level of HIE usage, measured via MU2 public use 
files for eligible hospitals in 2016. As a requirement of attestation to MU2, hospitals report 
the percentage of patient transfers sent with electronic summaries of care (eSCR). To 
successfully attest, the hospital must send at least 10 percent of transfers with eSCR. This 
measure is calculated by dividing the number of patient transitions or referrals in which an 
eSCR was transmitted using certified EHR technology (CEHRT) or an HIE or health 
information organization (HIO) by the total number of transfers of care a hospital completes 
during the 90-day MU reporting period.24 This measure has been used in previous work 
investigating how hospital factors and payment reform efforts relate to the level of HIE 
among hospitals.7,23 It is worth noting that the nature of this measure introduces possible 
confounding via selection bias for this aim. We discuss the implications and empirical 
evaluations of this selection bias in the limitations section. Additionally, it may be that 
hospitals already using HIE and attesting to MU2 may be insensitive to regulatory barriers, 
having already achieved HIE in their state’s regulatory environment. We investigate this 
specifically in aim one of our analysis.
State Health Information Exchange Consent Laws—The independent variables of 
interest capture state laws governing patient consent policies for the HIE that were in effect 
as of June 2016 and does not include the effective dates of each policy, thus precluding a 
longitudinal analysis. Schmit, et al. surveyed the HIE legal landscape as of 2016 and 
classified state laws that impacted HIE organizations and participants.11 Our independent 
variable captures the state law regarding patient consent for HIE. These laws are classified as 
opt-in, opt-out, or other. (Figure 1) The “other” group consists of state laws that are 
ambiguous or describe patient HIE participation as “voluntary” without specifying a consent 
approach. For example, in Texas, the relevant legislation stipulates that HIE organizations 
may “implement, promote, and facilitate the voluntary exchange of secure electronic health 
information” (Texas Health & Safety Code § 182.101). Ambiguous state policies were those 
that could not be interpreted as strictly opt-in or opt-out. For example, Nevada stipulates that 
patient consent must be obtained upon retrieval of information from an HIE (NRS § 
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439.589), but does not explicitly dictate the nature of that consent, nor does it clarify rules 
for consent to patient participation in the HIE prior to information retrieval. We 
operationalized this variable with opt-out policies as the reference group, to estimate the 
effect of opt-in consent policies compared to opt-out policies. Our hypothesis was that opt-in 
consent policies would be associated with greater likelihood of reporting regulatory barriers 
to exchange. We matched policies via the state each hospital reported in the 2016 AHA 
survey.
Hospital Characteristics—Control variables were constructed from the AHA IT 
Supplement to control for a variety of organizational, technological, and market factors that 
have been shown to be related to the adoption of IT and health information exchange in 
existing literature.8,25 We included the following control variables for organizational IT: 
hospital EHR adoption level (Less than Basic EHR, Basic EHR, or Comprehensive EHR);26 
primary EHR vendor (individual vendors for the top 90% of hospitals were listed 
individually, with all others classified as “other”). We also included a measure of whether or 
not the hospital used the dominant EHR in the hospital referral region (HRR), which has 
been found to be related to HIE capabilities.27 For our second aim, we included hospital 
program year in the MU program as a proxy for experience with MU. We controlled for the 
following hospital factors: participation in a regional health information organization 
(RHIO); ownership (for-profit, local government, and non-profit); size (less than 100 beds, 
between 100 and 400 beds, and more than 400 beds); health system membership; teaching 
hospital status; critical access hospital status; medical home status; participation in CMS’ 
bundled payments program and an Accountable Care Organization (ACO); percentage of 
total inpatient days for Medicare patients; and percentage of total inpatient days for 
Medicaid patients. Regional control variables included US Census Region where the 
hospital is located and urbanicity, defined by core-base statistical area codes (CBSA) of 
rural, micro, and metro. Finally, we included a measure of HRR market concentration using 
the Herfindahl-Hirschman Index (HHI). We used the total number of hospital beds per 
hospital in the HRR as the measure of hospital market share.28 This was classified into 
Federal Trade Commission categories of unconcentrated, moderately, and highly 
concentrated.29
Analytic Approach: Design and Statistical Analyses
We examined differences in hospitals under different HIE consent policy regimes, using chi-
squared analyses to test for bivariate relationships. We used logistic regression adjusting for 
hospital technology adoption levels and HIE participation as well as hospital and regional 
characteristics, with standard errors clustered at the state level to correct for correlation 
across hospitals in the same state. From these models, we computed marginal effects 
estimates and 95 percent confidence intervals for ease of interpretation. We also conducted 
subgroup analyses to disaggregate the findings from aim one across hospitals differing in 
their levels of technological sophistication. We divided our sample into hospitals attesting to 
MU (i.e. those with HIE volume performance data) and those not attesting to MU, and used 
the same logistic regression model. We compared these results to our main model including 
all hospitals to identify potential differences in the relationship between opt-in consent 
policies and reported regulatory barriers across these two groups of hospitals. This allowed 
Apathy and Holmgren Page 5













us to investigate the hypothesis that less technologically advanced hospitals were more likely 
to report regulatory barriers than relatively more technologically advanced hospitals.
For our second aim, we used multiple linear regression, controlling for hospital technology 
adoption and experience in the Meaningful Use program, organizational factors, and 
regional characteristics. We clustered standard errors at the state level. As a robustness check 
for both aims, we added controls for potential collider variables capturing hospital HIE 
capabilities that we excluded from our main regression models in separate regression models 
to validate that our primary estimates did not differ from those adjusting for these 




In the legal data collected by Schmit, et al., 34 states had HIE consent policies defined as 
either opt-in, opt-out, or other.11 The remaining states and the District of Columbia are 
classified as missing in our dataset. In 2016, 7 states had opt-in HIE consent policies, 15 
states had opt-out policies, and 12 were classified as having other approaches (Figure 1). In 
our primary regression model, there were 2,023 hospitals with complete data from these 34 
states. Of these hospitals, 478 were from opt-in states, 783 from opt-out states, and 762 from 
states classified as other.
Barriers to Health Information Exchange
On average, 13 percent of hospitals reported regulatory barriers to health information 
exchange in 2016. In our bi-variate analysis, 20 percent of hospitals in states with opt-in 
consent policies reported regulatory barriers to HIE, compared to 13 percent of hospitals in 
states with opt-out, ambiguous, or voluntary policies (Figure 2), a statistically significant 
difference (p<0.001). Hospitals also differed across consent policy types with respect to their 
RHIO participation, ownership, size, region, medical home status, critical access status, 
participation in ACOs and bundled payment programs, and location in urban or rural areas 
(Table 1). A complete table of descriptive statistics across all covariates can be found in 
eAppendix Table 1.
In our logistic regression, hospitals in states with opt-in consent policies had an 7.8 
percentage point higher probability of reporting regulatory barriers to health information 
exchange, compared to hospitals in states with opt-out policies (Average Marginal Effect 
(AME) = 0.087; p=0.034, Table 2). In a second model using other consent policies as the 
reference, neither opt-in nor opt-out policies illustrated a relationship with reporting 
regulatory barriers. Full regression results for our first aim, with both opt-out and other 
policies as the reference policy, are available in eAppendix Tables 2 and 3.
In our subgroup analyses stratifying hospitals by Meaningful Use attestation for health 
information exchange level, we found no evidence of a relationship between opt-in consent 
policies and reported regulatory barriers for hospitals that reported Stage 2 Meaningful Use 
attestation (AME=0.08; p=0.13, Table 2). However, finding that opt-in consent laws were 
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associated with perceived legal barriers to HIE held among the subsample of hospitals not 
attesting to Meaningful Use (AME=0.077; p=0.019, Table 2), which` may suggest that the 
burden of opt-in policies falls primarily on less technologically advanced hospitals. The full 
results of our subgroup analyses can be found in eAppendix Tables 4 and 5.
Finally, in our robustness check that included hospital HIE capabilities as potential collider 
variables, our primary aim one finding held in direction, magnitude, and significance 
(eAppendix Table 6). HIE capabilities of finding, sending, receiving, and using electronic 
patient health information were excluded from our main regression models examining 
consent policies and hospital-reported regulatory barriers to avoid collider bias, however 
these findings do not suggest that these variables constitute colliders in this analysis.
Volume of Health Information Exchange
Among hospitals reporting to MU2, on average, hospitals reported 43% of patient transfers 
were sent with an electronic summary of care record (Table 1). In bi-variate analyses of our 
second research aim, hospital HIE volume differed across state HIE consent policies, with 
hospitals in opt-in states reporting an average of 42 percent of transfers sent with eSCR 
compared to 45 percent and 41 percent of transfers in opt-out and other policy states, 
respectively (p=0.016). However, in multivariate linear regression adjusting for hospital 
EHR adoption, demographics and regional characteristics, we found no evidence of a 
relationship between opt-in state HIE consent policies and volume of HIE usage, compared 
to opt-out policies (ß=0.560; p=0.763, Table 2). Full regression results for the second aim 
can be found in eAppendix Table 7. Additionally, given the lower levels of HIE volume in 
opt-in states and the attenuation of that relationship in the adjusted model, we suspected that 
opt-in consent policies may be related to EHR adoption, which then would impact HIE 
volume. To test this, we conducted a multinomial logistic regression with consent policy 
type as the independent variable and EHR adoption level as the dependent variable. This test 
showed no significant relationship between these variables (eAppendix Figure 1).
Discussion
Our study is the first to directly compare opt-in and opt-out health information exchange 
consent policies across states. We found that, on average, hospitals in states with opt-in 
consent policies for HIE were more likely to report regulatory barriers to HIE compared to 
hospitals in states with opt-out consent policies, even when adjusting for a variety of hospital 
information technology, organizational, and market characteristics. This finding suggests 
that opt-in policies may uniquely contribute to hospital barriers to HIE compared to opt-out 
policies. Given the administrative burden that opt-in consent policies introduce,17 our 
findings are consistent with a larger body of work supporting the claim that opt-in policies 
are more burdensome to implement. However, policies requiring explicit consent such as 
these may serve an important protective role in the use of patient health information.
Our sub-group analyses found that the relationship between opt-in consent policies and 
reported regulatory barriers only held for hospitals not attesting to MU2 in 2016. Hospitals 
subject to opt-in consent but having some degree of interoperable HIE capabilities were not 
more likely to report regulatory barriers. This finding supports the interpretation that 
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regulatory barriers may be borne primarily by hospitals that lag in technological 
sophistication and health information exchange capabilities in particular, or that opt-in 
consent policies discourage health information exchange on the extensive margin only. Opt-
in consent policies may in turn further delay these hospitals in achieving interoperable health 
information exchange.
Despite hospitals’ increased likelihood of reporting regulatory barriers to HIE in the 
presence of opt-in policies, we found no evidence of a relationship between opt-in consent 
policies and volume of HIE usage. This finding suggests that consent policy type does not 
directly influence the amount of HIE in which a hospital engages, though this analysis is 
limited only to the subgroup of hospitals attesting to MU2 and, as noted above, no more 
likely to report regulatory barriers to HIE. Additionally, given the cross-sectional nature of 
our data, we are unable to observe hospitals’ reported regulatory barriers to HIE in prior 
years. Regulatory barriers to HIE, including opt-in consent policies, may have been more 
salient in previous years as hospitals were establishing HIE capabilities, and by 2016 these 
barriers may have been largely overcome.
Taken together, these findings illustrate that while opt-in consent regimes are related to 
barriers to HIE for hospitals, relatively technologically sophisticated hospitals use HIE at the 
same rate regardless of their state’s consent policy. That is to say that while opt-in consent 
policies may contribute to a variety of administrative or technical barriers, organizations are 
able to overcome these barriers if and when interoperable data exchange becomes an 
important institutional goal. Our findings fit with other work finding that both incentives and 
hospital technical capabilities relate to HIE volume.7,23
While we find opt-in consent policies are related to higher reported rates of regulatory 
barriers to HIE among hospitals, opt-out policies may not be strictly superior. Opt-out 
policies raise concerns among patients of violating rights to informed choice.32 While opt-
out consent policies are generally less burdensome for clinicians and administrators, and are 
fully within the law under HIPAA, some evidence shows that patients may prefer opt-in 
systems for HIE consent.33 Opt-in consent policies are often motivated by these twin forces 
that prioritize privacy and patient preference, despite the administrative burdens they may 
bring.32 Policymakers should carefully consider these trade-offs going forward in deciding 
how laws pertaining to HIE should be crafted.
Future studies should consider directly examining variation in consent laws across 
jurisdictions or hospitals in different jurisdictions that share substantial numbers of patients, 
as the regulatory differences specific to patient consent in these settings are likely to be 
highly salient to hospitals. Furthermore, studies should examine the extent to which the 
volume of HIE is associated with the ultimate goals of interoperable HIE, namely improving 
efficiency, quality of care, and eventually health outcomes.
Limitations
Our study has several limitations. First, the analysis is cross-sectional in nature and only 
representative of hospitals and state policies in 2016. Furthermore, we can draw no causal 
conclusions given the cross-sectional data and lack of exogenous variation. Given that both 
Apathy and Holmgren Page 8













the database of state HIE laws and Meaningful Use performance reporting are as of 2016, 
we were limited in our ability to analyze the effects of laws over time. States passed HIE 
laws over a number of years, further limiting longitudinal analysis. For example, the 
effective dates of consent laws range from June 2008 to March 2016, with two-thirds going 
into effect after 2011. Second, some states in the legal database contained missing values for 
certain laws, in particular consent policies. Despite the listwise deletion of hospital 
observations in states with missing values for HIE policies, our sample sizes remained 
relatively robust from the states that were included in the analysis. However, this limits the 
generalizability of our findings outside of states included in the analysis, and prevents us 
from drawing conclusions at the national level. Third, in the analysis for our second research 
aim, it is possible that our estimates are impacted by selection bias. We only observe 
hospitals that successfully attested to Meaningful Use, a sample that may exclude hospitals 
with systematically lower levels of health IT sophistication from those analyses. This may 
be especially pronounced in analyses of HIE volume due to the volume threshold required 
for MU2 attestation. However, previous work has found limited evidence of selection bias in 
this sample of hospitals.7 In this work, Lin, et al. used a Heckman selection model to 
identify if hospitals that did not attest to MU2 had lower predicted HIE volume compared to 
those that did. They found that the Heckman model estimates were essentially the same as 
multiple linear regression, indicating that using only MU2-attesting hospitals was unlikely to 
bias the findings. Furthermore, our measure of HIE usage – percentage of patient transfers 
sent with eSCR – has limitations in that it may not be perfectly sensitive to state consent 
policies, given that eSCR transitions have low administrative costs once exchange 
capabilities are in place. Nevertheless, we do find variation in this variable across hospitals, 
suggesting that rates of eSCR are not uniformly distributed.
Implications
Any policies states implement for health information exchange will have trade-offs. In the 
case of opt-in consent policies, states may choose to prioritize patient privacy, right to 
consent, and patient preferences at the cost of added administrative burden and regulatory 
hurdles for hospitals and providers. Policymakers should consider the existing legal 
structures related to health information exchange in their region and the technical 
capabilities of hospitals in their states to anticipate the burden that opt-in consent policies are 
likely to bring. Furthermore, federal policymakers tasked with reducing administrative 
burdens related to the use of EHRs – a specific provision of the 21st Century Cures Act – 
should consider that hospitals at varying levels of technological sophistication may 
experience different administrative burdens.
Conclusions
We compared opt-in state health information exchange consent policies to opt-out policies in 
2016, and found that hospitals in states with opt-in consent policies were 7.8 percentage 
points more likely to report experiencing regulatory barriers to HIE. However, hospitals 
attesting to MU2 in these states did not systematically engage in less HIE, suggesting that 
these barriers are not borne by more technologically advanced hospitals. Our results fit with 
previous literature emphasizing the added administrative burden of opt-in consent policies 
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compared to opt-out policies, especially for less technologically advanced hospitals. 
Policymakers should consider the complexity of regional differences in consent policies and 
the incidence of regulatory burdens when crafting HIE consent policies or guidance to 
hospitals for policy compliance.
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Variation in consent policies for health information exchange pose a challenge to 
realizing the goal of interoperable HIE. In particular, opt-in policies require explicit 
patient consent and may impose administrative burdens on hospitals sharing data.
• Hospitals in states with opt-in patient consent requirements for HIE are more 
likely to report regulatory barriers to exchange, compared to those in states 
with opt-out policies that assume consent.
• This finding only holds for less technologically advanced hospitals, 
suggesting that these hospitals may bear more of this burden.
• Among more technologically advanced hospitals, opt-in consent policy was 
not related to level of HIE.
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Figure 1. State HIE Consent Policiesa,b
a Source for legal data: Schmit CD, Wetter SA, Kash BA. Falling short: how state laws can 
address health information exchange barriers and enablers. Journal of the American Medical 
Informatics Association. 2017 Nov 2;25(6):635–44. Available from: https://doi.org/10.1093/
jamia/ocx122.
b Map illustrates differences in state laws pertaining to patient consent for health information 
exchange as of June 2016.
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Figure 2. Percentage of hospitals reporting regulatory barriers to health information exchange 
across consent policy typesa,b
a N=2,613
b Hospitals report “barriers when trying to electronically (not eFax) send, receive, or find 
(query) patient health information to/from other care settings or organizations.” We 
classified hospitals as experiencing regulatory barriers to HIE if they responded “Yes” to the 
following barrier: “The complexity of state and federal privacy and security regulations 
makes it difficult for us to determine whether it is permissible to electronically exchange 
patient health information.” Additional hospital statistics stratified by consent policy type 
are reported in Exhibit 3.
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Table 1.
Descriptive statistics of hospital sample, stratified by state consent policy type
a,b
Overall Stratified by Consent Policy Type
Opt Out Opt In Other
n 3624 1015 648 950
Report Regulatory Barriers to HIE*** 467 (12.9) 129 (12.7) 131 (20.2) 125 (13.2)
% of Transfers Sentw/ ESCR, mean (sd)** 43.0(24.3) 45.0(25.9) 41.7 (24.0) 41.2 (22.4)
EHR Adoption Level
 Less than Basic 779 (22.2) 190 (19.4) 128 (20.2) 199 (21.5)
 Basic EHR 981 (27.9) 274 (28.0) 163 (25.7) 264 (28.5)
 Comprehensive EHR 1756(49.9) 513 (52.5) 343 (54.1) 464 (50.1)
Hospital Uses Dominant EHR Vendor 1483 (42.3) 406 (41.3) 284 (44.9) 405 (43.5)
Ownership Type***
 Local Government 807 (22.3) 182 (17.9) 139 (21.5) 212 (22.3)
 For Profit Hospital 720 (19.9) 140 (13.8) 116 (17.9) 244 (25.7)
 Nonprofit Hospital 2097(57.9) 693 (68.3) 393 (60.6) 494 (52.0)
Size**
 Small (<100 beds) 1834(50.9) 529 (52.5) 292 (45.2) 482 (51.0)
 Midsize (100–400beds) 1384(38.4) 385 (38.2) 268 (41.5) 369 (39.0)
 Large (>400 beds) 382 (10.6) 93 (9.2) 86 (13.3) 94 (9.9)
Region***
 North Central 1158(32.0) 499 (49.2) 138 (21.3) 109 (11.5)
 Northeast 508 (14.0) 196 (19.3) 212 (32.7) 30 (3.2)
 South 1389(38.3) 208 (20.5) 298 (46.0) 437 (46.0)
 West 569 (15.7) 112 (11.0) 0 (0.0) 374 (39.4)
RHIO Participation*** 2155(60.9) 663 (67.1) 426 (66.9) 528 (56.7)
Medical Home** 817 (28.7) 231 (27.3) 163 (32.5) 185 (22.9)
Health System Member 2360(65.6) 659 (65.4) 439 (68.1) 622 (65.8)
Teaching Hospital 1164(32.4) 332 (32.9) 239 (37.1) 304 (32.2)
Critical Access Hospital*** 831 (23.1) 283 (28.1) 134 (20.8) 181 (19.2)
ACO Member*** 1064(36.2) 358 (41.7) 205 (40.0) 242 (29.8)
Bundled Payment Participant* 572 (19.6) 358 (42.3) 204 (40.4) 242 (30.0)
CBSA Type***
 Rural 680 (18.9) 220 (21.8) 106 (16.4) 138 (14.6)
 Micro 541 (15.0) 173 (17.2) 86 (13.3) 127 (13.4)
 Metro 2375(66.0) 615 (61.0) 453 (70.2) 680 (72.0)
a
Selected hospital characteristics. Numbers of hospitals are reported with percentages of the sample in parentheses. A full table with all 
characteristics used in multiple regression models can be found in the supplementary appendix.
b
Significance levels:
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